% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/plot.jointSurroPenalloocv.R
\name{plot.jointSurroPenalloocv}
\alias{plot.jointSurroPenalloocv}
\title{Plot of trials leave-one-out crossvalidation Outputs from the one-step Joint surrogate model for evaluating a 
canditate surrogate endpoint.}
\usage{
\method{plot}{jointSurroPenalloocv}(x, unusedtrial = NULL, xleg = "bottomleft", 
yleg = NULL, main = NULL, xlab = "Trials", 
ylab = "Log Hazard ratio of the true endpoint", 
legend = c("Beta observed", "Beta predict"), ...)
}
\arguments{
\item{x}{An object inherent from the \code{jointSurroPenalloocv} Class}

\item{unusedtrial}{Vector of unconsidered trials, may be due to the fact that the 
predicted treatment effects on true endpoint have an outlier. In this case, 
one can drop from the data the trials with very hight absolute predicted value}

\item{xleg}{X-coordinate for the location of the legend.}

\item{yleg}{Y-coordinate for the location of the legend, the default is \code{NULL}}

\item{main}{An overall title for the plot: see \link{title}.}

\item{xlab}{A title for the x axis: see \link{title}.}

\item{ylab}{A title for the y axis: see \link{title}.}

\item{legend}{A vector of characters string of length >= 1 to appear in the legend}

\item{...}{other unused arguments.}
}
\value{
This function displays the boxplots corresponding to the number of trials in the 
dataset. Each boxplot includes 3 elements corresponding to the predicted treatment effect on true endpoint
with the prediction interval. The circles inside or outside the boxplot represent the observed
treatment effects on true endpoint. For each trial with convergence issues or outliers, the boxplot is replaced
by a dash. In this case, we display in the title of the figure a vector of these trials, if argument \code{main} 
is set to \code{NULL}. The function returns the list of unused trials.
}
\description{
{
Plot of trials leave-one-out crossvalidation Outputs for evaluating the joint surrogate model 
}
}
\examples{


\dontrun{
# Generation of data to use 
 data.sim <- jointSurrSimul(n.obs=300, n.trial = 10,cens.adm=549.24,
             alpha = 1.5, theta = 3.5, gamma = 2.5, zeta = 1, sigma.s = 0.7,
             sigma.t = 0.7, cor = 0.8, betas = -1.25, betat = -1.25,
             full.data = 0, random.generator = 1, seed = 0,
             nb.reject.data = 0)

###--- Joint surrogate model ---###
 
joint.surro.sim.MCGH <- jointSurroPenal(data = data.sim, int.method = 2,
                        nb.mc = 300, nb.gh = 20, print.iter = T)
        
# Example of loocv taking into accountn ony trial 2 trials (1 and 3)
dloocv <- loocv(joint.surro.sim.MCGH, unusedtrial = c(2,4:10))

plot(x = dloocv, xleg = "topright", bty = "n")

}

}
\references{
Burzykowski T, Buyse M (2006). "Surrogate threshold effect: an alternative 
measure for meta-analytic surrogate endpoint validation." Pharmaceutical 
Statistics, 5(3), 173-186.ISSN 1539-1612.
}
\seealso{
\code{\link{loocv}}
}
\author{
Casimir Ledoux Sofeu \email{casimir.sofeu@u-bordeaux.fr}, \email{scl.ledoux@gmail.com} and 
Virginie Rondeau \email{virginie.rondeau@inserm.fr}
}
\keyword{loocv}
\keyword{plot}
\keyword{prediction}
\keyword{surrogate}
